🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsLab Results & BiomarkersLiver enzymes trending down on GLP-1 — ALT/AST normalization Page 2

Liver enzymes trending down on GLP-1 — ALT/AST normalization

MASHdoc_SA Sun, Jun 7, 2026 at 5:07 PM 17 replies 389 viewsPage 2 of 4
kate.chem
VIP Member
3,890
17,654
Dec 2023
California
Jun 7, 2026 at 7:54 PM#6
MASHdoc_SA said:
The liver data is among the strongest non-weight findings in the class.

Liver ultrasound comparison for liver and MASH: my hepatologist ordered serial ultrasounds to track NAFLD regression.

Baseline: "Moderate hepatic steatosis, liver span 17.2cm, echogenic texture consistent with fat infiltration"
Month 8: "Mild steatosis, liver span 15.8cm, improved echogenicity"
Month 14: "Minimal to no steatosis, normal liver span 14.5cm, normal echotexture"

My liver literally shrank and de-fattened. The ultrasound tech said she's seen this pattern increasingly in GLP-1 patients and it's remarkable how consistently the fatty liver resolves.

Last edited: Jun 7, 2026 at 10:54 PM
20 23steve_okc, dave_SLC, FDA_TrackerJim and 17 others
Reply Quote Save Share Report
dan_philly
Member
456
2,123
Jul 2024
Philadelphia, PA
Jun 7, 2026 at 9:00 PM#7

One thing that is still open after sean_dublin’s answer:

What would you measure differently if you were starting again?

21 24AmyNC_wife, SkepticalSean, Dr.CardioMD and 18 others
Reply Quote Save Share Report
julia.endo
Senior Member
1,890
9,012
Feb 2024
Cincinnati, OH
Jun 7, 2026 at 10:06 PM#8
kate.chem said:
Liver ultrasound comparison for liver and MASH: my hepatologist ordered serial ultrasounds to track NAFLD regression.

NASH/MAFLD therapeutic landscape and liver and MASH: GLP-1 agonists are emerging as potential first-line NASH therapy. The Phase 2b data for semaglutide showed 59% NASH resolution (vs 17% placebo) with 43% achieving fibrosis improvement[1].

Mechanism: GLP-1R activation reduces hepatic lipogenesis, increases fatty acid oxidation, reduces hepatic inflammation, and may directly reduce hepatic stellate cell activation (fibrosis pathway).

With resmetirom (thyroid hormone receptor agonist) recently approved for NASH, the field is evolving rapidly. Combination approaches (GLP-1 + resmetirom) are being explored.

References:
[1] Newsome PN, et al. N Engl J Med. 2021;384(12):1113-1124.
Last edited: Jun 8, 2026 at 4:06 AM
22 0hans_munich, jason_sac26, chris_chi24 and 19 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
MASHdoc_SA
Member
456
2,345
Aug 2024
San Antonio, TX
Jun 7, 2026 at 11:11 PM#9

OP back with an update, since a thread like this is useless without one.

Update — I was wrong in the opening post, specifically about the direction. Correcting it here rather than editing it away.

23 1LabKate, kate.chem, DataDave and 20 others
Reply Quote Save Share Report
DadBodDave
Member
187
923
Nov 2024
Ohio
Jun 8, 2026 at 4:26 AM#10
julia.endo said:
NASH/MAFLD therapeutic landscape and liver and MASH: GLP-1 agonists are emerging as potential first-line NASH therapy.

Agreed, and one caution: a single measurement is not a measurement. Anything that moves day to day needs a trend before it means anything at all.

Ask again with the specifics and you will get a better answer than this one.

Last edited: Jun 8, 2026 at 7:26 AM
49 24JakeBK_lifts, DerekSJ_a1c, paige_pharma and 46 others
Reply Quote Save Share Report

Similar Threads

Optimal lab testing frequency on GLP-1 — evidence-based schedule5 replies
A1C from 7.2 to 5.1 — my bloodwork transformation19 replies
Thyroid function monitoring on GLP-1 — TSH and free T4 trends3 replies
Lipid panel improvements mega-thread — share your numbers19 replies
Kidney function on semaglutide — eGFR and UACR improvements21 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register